Activation of AMPK by chitosan oligosaccharide in intestinal epithelial cells: Mechanism of action and potential applications in intestinal disorders

Biochemical Pharmacology

Volumn 96, Issue 3, 2015, Pages 225-236

  Muanprasat, Chatchai ^a   Wongkrasant, Preedajit ^a   Satitsri, Saravut ^a   Moonwiriyakit, Aekkacha ^a   Pongkorpsakol, Pawin ^a   Mattaveewong, Tharinee ^a   Pichyangkura, Rath ^b   Chatsudthipong, Varanuj ^a  

^a Mahidol University ^*  (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

AMP activated protein kinase; Chitosan oligosaccharide; Colorectal cancer; Diarrhea; Intestinal epithelial cells

Indexed keywords

BETA CATENIN; CASPASE 3; CHITOSAN; CHITOSAN OLIGOSACCHARIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGOSACCHARIDE; PHOSPHOLIPASE C; POLYMER; UNCLASSIFIED DRUG; AZOXYMETHANE; CALCIUM; CASR PROTEIN, MOUSE; CHOLERA TOXIN; CTNNB1 PROTEIN, MOUSE; DEXTRAN SULFATE; G PROTEIN COUPLED RECEPTOR; GASTROINTESTINAL AGENT; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR;

ABERRANT CRYPT FOCUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACO 2 CELL LINE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHEMOPROPHYLAXIS; COLITIS; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; ENDOPLASMIC RETICULUM; ENTEROPATHY; ENZYME ACTIVATION; INFLAMMATION; INTESTINE EPITHELIUM CELL; INTESTINE FLUID; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIGHT JUNCTION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COLORECTAL NEOPLASMS; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTESTINE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AZOXYMETHANE; BETA CATENIN; CALCIUM; CASPASE 3; CELL LINE, TUMOR; CHITOSAN; CHOLERA TOXIN; COLITIS; COLORECTAL NEOPLASMS; DEXTRAN SULFATE; EPITHELIAL CELLS; GASTROINTESTINAL AGENTS; GENE EXPRESSION REGULATION; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; INTESTINES; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TYPE C PHOSPHOLIPASES;

EID: 84934798838     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2015.05.016     Document Type: Article

References (40)

1. D.G. Hardie, and M.L. Ashford AMPK: regulating energy balance at the cellular and whole body levels Physiology (Bethesda) 29 2014 99 107
2. K.R. Hallows, P.F. Mount, and N.M. Pastor-Soler Power DA. Role of the energy sensor AMP-activated protein kinase in renal physiology and disease Am. J. Physiol. Renal. Physiol. 298 2010 F1067 F1077
3. T. Yano, T. Matsui, A. Tamura, M. Uji, and S. Tsukita The association of microtubules with tight junctions is promoted by cingulin phosphorylation by AMPK J. Cell Biol. 203 2013 605 614
4. M.J. Caplan, P. Seo-Mayer, and L. Zhang Epithelial junctions and polarity complexes and kinases Curr. Opin. Nephrol. Hyperten. 17 2008 506 512
5. B. Zheng, and L.C. Cantley Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase Proc. Natl. Acad. Sci. U.S.A. 104 2007 819 822
6. L. Zhang, J. Li, L.H. Young, and M.J. Caplan AMP-activated protein kinase regulates the assembly of epithelial tight junctions Proc. Natl. Acad. Sci. U.S.A. 103 2006 17272 17277
7. J.D. King Jr., A.C. Fitch, J.K. Lee, J.E. McCane, D.O. Mak, and J.K. Foskett AMP-activated protein kinase phosphorylation of the R domain inhibits PKA stimulation of CFTR Am. J. Physiol. Cell Physiol. 297 2009 C94 C101
8. C. Muanprasat, and V. Chatsudthipong Cholera pathophysiology and emerging therapeutic targets Future Med. Chem. 5 2013 781 798
9. A.C. Rogers, L. Huetter, N. Hoekstra, D. Collins, A. Collaco, and A.W. Baird Activation of AMPK inhibits cholera toxin stimulated chloride secretion in human and murine intestine PloS One 8 2013 e69050
10. R.Y. Su, Y. Chao, T.Y. Chen, D.Y. Huang, and W.W. Lin 5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNF{alpha}-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling Mol. Cancer Therap. 6 2007 1562 1571
11. W. Li, B. Hua, S.M. Saud, H. Lin, W. Hou, and M.S. Matter Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice Mol. Carcinog. 2014
12. S.J. Koh, J.M. Kim, I.K. Kim, S.H. Ko, and J.S. Kim Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer J. Gastroenterol. Hepatol. 29 2014 502 510
13. E. Zulato, F. Bergamo, A. De Paoli, G. Griguolo, G. Esposito, and G.L. De Salvo Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab Br. J. Cancer 111 2014 25 32
14. M.A. Anwar, W.A. Kheir, S. Eid, J. Fares, X. Liu, and A.H. Eid Colorectal and prostate cancer risk in diabetes: metformin, an actor behind the scene J. Cancer 5 2014 736 744
15. N. Thadathil, and S.P. Velappan Recent developments in chitosanase research and its biotechnological applications: a review Food Chem. 150 2014 392 399
16. G. Lodhi, Y.S. Kim, J.W. Hwang, S.K. Kim, Y.J. Jeon, and J.Y. Je Chitooligosaccharide and its derivatives preparation and biological applications BioMed Res. Int. 2014 2014 654913
17. J.Y. Je, and S.K. Kim Chitooligosaccharides as potential nutraceuticals: production and bioactivities Adv. Food Nutrit. Res. 65 2012 321 336
18. M. Yousef, R. Pichyangkura, S. Soodvilai, V. Chatsudthipong, and C. Muanprasat Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action Pharmacol. Res. 66 2012 66 79
19. S. Huber, N. Gagliani, L.A. Zenewicz, F.J. Huber, L. Bosurgi, and B. Hu IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine Nature 491 2012 259 263
20. L. Gama, L.M. Baxendale-Cox, and G.E. Breitwieser Ca2+-sensing receptors in intestinal epithelium Am. J. Physiol. 273 1997 C1168 C1175
21. Z. Saidak, M. Brazier, S. Kamel, and R. Mentaverri Agonists and allosteric modulators of the calcium-sensing receptor and their therapeutic applications Mol. Pharmacol. 76 2009 1131 1144
22. S.A. Hawley, M.D. Fullerton, F.A. Ross, J.D. Schertzer, C. Chevtzoff, and K.J. Walker The ancient drug salicylate directly activates AMP-activated protein kinase Science 336 2012 918 922
23. Y. Chi, K. Li, Q. Yan, S. Koizumi, L. Shi, and S. Takahashi Nonsteroidal anti-inflammatory drug flufenamic acid is a potent activator of AMP-activated protein kinase J. Pharmacol Exp. Therap. 339 2011 257 266
24. S.H. Lee, M. Senevirathne, C.B. Ahn, S.K. Kim, and J.Y. Je Factors affecting anti-inflammatory effect of chitooligosaccharides in lipopolysaccharides-induced RAW264.7 macrophage cells Bioorg. Med. Chem. Lett. 19 2009 6655 6658
25. S. Marchi, S. Patergnani, and P. Pinton The endoplasmic reticulum-mitochondria connection: one touch, multiple functions Biochim. Biophys. Acta 2014 1837 461 469
26. F. Jouret, J. Wu, M. Hull, V. Rajendran, B. Mayr, and C. Schofl Activation of the Ca(2)+-sensing receptor induces deposition of tight junction components to the epithelial cell plasma membrane J. Cell Sci. 126 2013 5132 5142
27. A. Salminen, J.M. Hyttinen, and K. Kaarniranta AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan J. Mol. Med. (Berl.) 89 2011 667 676
28. S. Reagan-Shaw, M. Nihal, and N. Ahmad Dose translation from animal to human studies revisited FASEB J. Off. Public. Feder. Am. Soc. Exp. Biol. 22 2008 659 661
29. T. Szkudelski, and K. Szkudelska Resveratrol and diabetes: from animal to human studies Biochim. Biophys. Acta 2014
30. G.J. Gowans, and D.G. Hardie AMPK a cellular energy sensor primarily regulated by AMP Biochem. Soc. Trans. 42 2014 71 75
31. T.A. Almabrouk, M.A. Ewart, I.P. Salt, and S. Kennedy Perivascular fat, AMP-activated protein kinase and vascular diseases Br. J. Pharmacol. 171 2014 595 617
32. I. Pernicova, and M. Korbonits Metformin - mode of action and clinical implications for diabetes and cancer Nature Rev. Endocrinol. 10 2014 143 156
33. V. Vingtdeux, L. Giliberto, H. Zhao, P. Chandakkar, Q. Wu, and J.E. Simon AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism J. Biol. Chem. 285 2010 9100 9113
34. X. Fan, J. Wang, J. Hou, C. Lin, A. Bensoussan, and D. Chang Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway J. Trans. Med. 13 2015 450
35. A. Martin-Montalvo, E.M. Mercken, S.J. Mitchell, H.H. Palacios, P.L. Mote, and M. Scheibye-Knudsen Metformin improves healthspan and lifespan in mice Nature Commun. 4 2013 2192
36. N.L. Price, A.P. Gomes, A.J. Ling, F.V. Duarte, A. Martin-Montalvo, and B.J. North SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function Cell Metab. 15 2012 675 690
37. S. Ayyadevara, P. Bharill, A. Dandapat, C. Hu, M. Khaidakov, and S. Mitra Aspirin inhibits oxidant stress, reduces age-associated functional declines, and extends lifespan of Caenorhabditis elegans Antioxid. Redox Signal. 18 2013 481 490
38. J.N. Kim, I.Y. Chang, H.I. Kim, and S.P. Yoon Long-term effects of chitosan oligosaccharide in streptozotocin-induced diabetic rats Islets 1 2009 111 116
39. C. Ju, W. Yue, Z. Yang, Q. Zhang, X. Yang, and Z. Liu Antidiabetic effect and mechanism of chitooligosaccharides Biol. Pharma. Bull. 33 2010 1511 1516
40. X. Dai, P. Chang, Q. Zhu, W. Liu, Y. Sun, and S. Zhu Chitosan oligosaccharides protect rat primary hippocampal neurons from oligomeric beta-amyloid 1-42-induced neurotoxicity Neurosci. Lett. 554 2013 64 69